Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Context Therapeutics
Biotech
20-year Novo vet lands first CEO role—Chutes & Ladders
20-year Novo vet lands first CEO role. Acadia bulks up rare disease digs with BMS vet. EpiVax bags Big Pharma vet as CSO.
Darren Incorvaia
,
Zoey Becker
May 30, 2025 8:30am
Context builds bispecific bank with $133M biobucks deal
Sep 23, 2024 11:20am
Assembly, Context and Innate add to pile of dumped R&D prospects
Mar 23, 2023 8:00am
Context cuts excess fat to carry biotech into ‘24
Sep 28, 2022 11:00am
